FIRST CHINA PHARMACEUTICAL GROUP, INC. Comprehensive Income
FIRST CHINA PHARMACEUTICAL GROUP, INC. reported Comprehensive Income of $992.23 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2012-11-19
- FIRST CHINA PHARMACEUTICAL GROUP, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-09-30 was $992.23K, a 26.86% increase year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-06-30 was $2.29M, a 35.63% increase year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-03-31 was -$1.18M.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-09-30 was $782.15K, a 23.54% decline year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was $981.31K, a 64.75% decline from fiscal 2010.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was $2.78M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 21 month |
|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $992.23K 10-Q · filed 2012-11-19 | $3.29M derived: sum of 2 quarters · filed 2012-11-19 | $1.08M 10-Q · filed 2012-11-19 | |||||
| 2012-06-30 | $2.29M 10-Q/A · filed 2012-08-21 | $722.52K 10-Q/A · filed 2012-08-21 | ||||||
| 2012-03-31 | -$1.18M 10-Q · filed 2012-05-18 | |||||||
| 2011-12-31 | $4.42M 10-KT/A · filed 2012-11-19 | $4.72M 10-KT · filed 2012-05-02 | $2.85M 10-KT · filed 2012-05-02 | |||||
| 2011-09-30 | $782.15K 10-Q · filed 2012-11-19 | $438.67K 10-Q · filed 2011-11-14 | $2.47M derived: sum of 2 quarters · filed 2012-11-19 | $2.00M 10-Q · filed 2012-11-19 | $713.05K 10-Q · filed 2011-11-14 | |||
| 2011-06-30 | $1.69M 10-Q/A · filed 2012-08-21 | $772.88K 10-Q/A · filed 2011-08-24 | $1.21M 10-Q/A · filed 2012-08-21 | $51.12K 10-Q/A · filed 2011-08-24 | ||||
| 2011-03-31 | -$454.60K 10-Q · filed 2012-05-18 | $981.31K 10-KT/A · filed 2012-11-19 | ||||||
| 2010-09-30 | $1.02M 10-Q · filed 2011-11-14 | $1.92M derived: sum of 2 quarters · filed 2011-12-02 | $2.73M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $899.13K 10-Q/A · filed 2011-12-02 | $1.71M 10-Q/A · filed 2011-12-02 | ||||||
| 2010-03-31 | $2.78M 10-KT/A · filed 2012-11-19 |